How to increase HDL

Reading Document
Medical Text Search

how to increase HDL cholesterol lifestyle diet exercise

Medical Text Search

HDL raising medications pharmacological treatment niacin fibrates

GradeResponse
GradeResponse

How to Increase HDL Cholesterol

HDL ("good") cholesterol helps clear atherogenic lipids from vessel walls. Strategies fall into lifestyle and pharmacological categories.

Lifestyle Modifications (First-Line)

Per the 2018 AHA/ACC/Multisociety Cholesterol Guidelines, lifestyle changes are the critical foundation for improving lipid profiles, including HDL:
StrategyEffect on HDLNotes
Aerobic exercise↑ 5–10%150+ min/week of moderate-intensity; most potent lifestyle modifier
Smoking cessation↑ 5–10%Smoking actively suppresses HDL
Weight loss↑ ~1 mg/dL per 3 kg lostEven modest loss helps
Reduced refined carbs/sugar↑ modestReplacing carbs with unsaturated fats is beneficial
Moderate alcohol↑ modestBenefit does not justify starting alcohol use; heavy use is harmful
Healthy dietary fats↑ modestReplace trans/saturated fats with monounsaturated and polyunsaturated fats (olive oil, nuts, avocado)
Mediterranean-style diet↑ HDL, ↓ CV riskAHA-endorsed heart-healthy dietary pattern
Additional dietary adjuncts: phytosterols and viscous soluble fiber may help overall dyslipidemia management (ACC/AHA guidelines, p. 8).

Pharmacological Options

When lifestyle changes are insufficient, especially in the context of atherogenic dyslipidemia (low HDL + high triglycerides + small dense LDL):
  • Niacin (nicotinic acid): Most potent HDL-raising drug — can raise HDL by 15–35%. However, large trials (AIM-HIGH, HPS2-THRIVE) did not show added CV benefit when added to statin therapy, so its use has declined.
  • Fibrates (e.g., fenofibrate, gemfibrozil): Favorably affect all components of atherogenic dyslipidemia — raise HDL, lower triglycerides, and shift LDL to larger, less atherogenic particles. Best evidence in patients with high TG + low HDL (Management of Dyslipidemia and Prevention of Cardiovascular Disease, p. 47).
  • Statins: Primarily lower LDL, but do produce modest HDL increases (5–10%).
  • CETP inhibitors (e.g., anacetrapib, obicetrapib): Raise HDL dramatically but clinical outcomes have been mixed; not widely in clinical use.

Key Takeaway

Lifestyle modification — particularly regular aerobic exercise and smoking cessation — has the strongest evidence for raising HDL. Pharmacological HDL-raising has not consistently translated to reduced cardiovascular events, so the focus in guidelines remains on lowering LDL and overall ASCVD risk reduction, with lifestyle as the cornerstone.
⚠️ Always discuss lipid management with a healthcare provider, particularly before starting any medications.
This is a shared conversation. Sign in to Orris to start your own chat.